Ftse Mib
34.639,34
0,52%
DAX
18.758,27
0,41%
S&P 500
5.307,01
0,00%
NASDAQ
16.801,54
0,00%
Bitcoin
69.731,32
0,91%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Natera Inc (NTRA) Natera Inc (NTRA) Notizie

Natera Inc

NTRA
108,51
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:47:45
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/5/202413:30BWNatera Announces New MRD Data in Multiple Tumor Types, to be..
20/5/202422:25EDGAR2Form 144 - Report of proposed sale of securities
18/5/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202422:56EDGAR2Form 144 - Report of proposed sale of securities
11/5/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:27EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:13EDGAR2Form 8-K - Current report
09/5/202422:05BWNatera Reports First Quarter 2024 Financial Results
04/5/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/5/202414:00BWNew Natera Publication Bolsters Evidence for Extended..
01/5/202422:05BWNatera to Report its First Quarter 2024 Results on May 9
01/5/202413:00BWNatera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians..
22/4/202414:00BWNatera Announces Significant Milestone with 200+..
11/4/202414:00BWNatera Announces Publication of Largest Prospective dd-cfDNA..
08/4/202414:00BWNatera Announces New Data From Two Studies Extending the..
05/4/202413:00BWNatera Announces Positive Surveillance Analysis from the..
01/4/202414:00BWNatera and Alliance for Clinical Trials in Oncology Announce..
18/3/202412:00BWNatera Announces Phase III Randomized CIRCULATE Trial in..
14/3/202413:00BWNew KDIGO Guideline Supports Genetic Testing for the..
12/3/202413:00BWNatera to Present New Data at the 2024 SGO Annual Meeting on..
09/3/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202414:00BWNatera Announces Commercial Coverage for Prospera™ Kidney..
05/3/202422:34EDGAR2Form 144 - Report of proposed sale of securities
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
29/2/202417:35EDGAR2Form 144 - Report of proposed sale of securities
29/2/202414:00BWNatera to Participate in March Investor Conferences
28/2/202422:11EDGAR2Form 8-K - Current report
28/2/202422:05BWNatera Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202422:27EDGAR2Form 144 - Report of proposed sale of securities
27/2/202414:00BWNatera Announces Next Phase of CareDx Patent Infringement..
26/2/202413:00BWMedicare Extends Coverage of Natera’s Signatera™ MRD Test to..
24/2/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 108,51

La tua Cronologia

NASDAQ
NTRA
Natera
TSX
CGDV
CI Global Minimum Downsi...
USOTC
EWIIF
Edinburgh Worldwide Inve... (PK)
USOTC
VEJID
Veji (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network